Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.

Summary, in English

The alleged efficacy of pharmaceutical industry self-regulation has been used to repudiate increased government oversight over promotional activity. European politicians and industry have cited Sweden as an excellent example of self-regulation based on an ethical code. This paper considers antidepressant advertising in Sweden to uncover the strengths and weaknesses of self-regulation.

• Author: Anna Zetterqvist; Shai Mulinari
• Department/s: Cardiovascular Research - Immunity and Atherosclerosis; Diabetic Complications; Gender Studies; EXODIAB: Excellence of Diabetes Research in Sweden
• Publishing year: 2013
• Language: English
• Publication/Series: PLoS ONE
• Volume: 8
• Issue: 5
• Full text: - 611 kB; Download statistics
• Links: http://www.ncbi.nlm.nih.gov/pubmed/23650519?dopt=Abstract; http://dx.doi.org/10.1371/journal.pone.0062609
• Document type: Journal article
• Publisher: Public Library of Science (PLoS)
• Topic: Health Care Service and Management, Health Policy and Services and Health Economy
• Keywords: Advertising; Antidepressants; Drug Industry; Sweden; Codes of ethics
• Status: Published
• Project: After the success with the new generation antidepressants: Experiences, practices, discourses and changes in the self.
• Research group: Cardiovascular Research - Immunity and Atherosclerosis; Diabetic Complications
• ISBN/ISSN/Other: ISSN: 1932-6203